A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Fung, Scott ^{[3
]}

Ahn, Sang Hoon ^{[4
]}

Chuang, Wan-Long ^{[5
]}

Ramji, Alnoor ^{[6
]}

Tak, Won Young ^{[7
]}

Chen, Chiyi ^{[8
]}

Tam, Edward ^{[9
]}

Bae, Ho ^{[10
]}

Ma, Xiaoli ^{[11
]}

Flaherty, John F. ^{[12
]}

Gaggar, Anuj ^{[12
]}

Lau, Audrey ^{[12
]}

Feierbach, Becket ^{[12
]}

Wu, George ^{[12
]}

Suri, Vithika ^{[12
]}

Subramanian, Mani ^{[12
]}

Trinh, Huy N. ^{[13
]}

Yoon, Seung Kew ^{[14
]}

Agarwal, Kosh ^{[15
]}

Lim, Young-Suk ^{[16
]}

Chan, Henry ^{[17
]}

机构：

[1] Univ Milan, Div Gastroenterol & Hepatol, Milan, Italy

[2] Univ Hosp Vall dHebron, Barcelona, Spain

[3] Univ Hlth Network, Toronto, ON, Canada

[4] Yonsei Univ, Seoul, South Korea

[5] Kaohsiung Med Univ, Kaohsiung, Taiwan

[6] Gastrointestinal Res Inst, Vancouver, BC, Canada

[7] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[8] Chia Yi Christian Hosp, Chiayi, Taiwan

[9] LAIR Ctr, Vancouver, BC, Canada

[10] St Vincents Med Ctr, Los Angeles, CA USA

[11] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA

[12] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[13] San Jose Gastroenterol, San Jose, CA USA

[14] Catholic Univ Korea, Seoul, South Korea

[15] Kings Coll Hosp London, London, England

[16] Univ Ulsan, Coll Med, Seoul, South Korea

[17] Prince Wales Hosp, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30928-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-183

引用

页码：E470 / E471

页数：2

共 50 条

[31] Long-term (96-week) efficacy and safety after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-infected, virologically suppressed adults
Raffi, Francois
Orkin, Chloe
Clarke, Amanda
Slama, Laurence
Gallant, Joel
Daar, Eric
Yan, Mingjin
Abram, Michael E.
Friborg, Sandra
Cheng, Andrew
Rhee, Martin
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[32] Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study
Bae, Ho S.
Lim, Young-Suk
Trinh, Huy
Heo, Jeong
Chuang, Wan-Long
Hui, Aric Josun
Elkhashab, Magdy
Tan, Susanna K.
Mo, Shuyuan
Guion, Matthew
Jump, Belinda
Flaherty, John
Suri, Vithika
Gaggar, Anuj
Tsang, Tak Yin Owen
Andreone, Pietro
Janssen, Harry
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S567 - S567
[33] Efficacy and safety of switching therapy from tenofovir disoproxil fumarate to tenofovir alafenamide for hepatitis B virus infection
Kaneko, Shun
Kurosaki, Masayuki
Tamaki, Nobuharu
Itakura, Jun
Kirino, Sakura
Watakabe, Keiya
Osawa, Leona
Okada, Mao
Wan, Wang
Shimizu, Takao
Higuchi, Mayu
Takaura, Kenta
Yasui, Yutaka
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Takahashi, Yuka
Izumi, Namiki
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E469 - E469
[34] Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with renal impairment: week 48 results from a phase 2 open label study
Janssen, Harry
Lampertico, Pietro
Chen, Chi-Yi
Heo, Jeong
Fournier, Claire
Ahn, Sang Hoon
Tsang, Tak Yin Owen
Coffin, Carla
Reggiani, Giulio Marchesini
Huang, Yi-Hsiang
Hui, Aric Josun
Elkhashab, Magdy
Chen, Chien-Hung
Jafri, Syed Mohammed Raza
Tan, Susanna
Mo, Shuyuan
Suri, Vithika
Flaherty, John F.
Gaggar, Anuj
Subramanian, Mani
Agarwal, Kosh
Chuang, Wan-Long
Gane, Edward
Lim, Young-Suk
JOURNAL OF HEPATOLOGY, 2020, 73 : S866 - S867
[35] Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with hepatic impairment: week 48 results from a phase 2 open label study
Lim, Young-Suk
Lin, Chun-Yen
Heo, Jeong
Bae, Ho
Chuang, Wan-Long
Hui, Aric Josun
Elkhashab, Magdy
Trinh, Huy
Tan, Susanna
Mo, Shuyuan
Flaherty, John F.
Suri, Vithika
Gaggar, Anuj
Subramanian, Mani
Tsang, Tak Yin Owen
Ryder, Stephen
Andreone, Pietro
Janssen, Harry
JOURNAL OF HEPATOLOGY, 2020, 73 : S872 - S872
[36] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 96 WEEKS IN CHRONIC HBV (CHB) PATIENTS WITH RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE (TDF)
Chan, Henry Lik-Yuen
Buti, Maria
Flisiak, Robert
Ryder, Stephen
Streinu-Cercel, Adrian
Flaherty, John F.
Gaggar, Anuj
Mo, Shuyuan
Subramanian, G. Mani
Zoulim, Fabrian
Andreone, Pietro
Marcellin, Patrick
GUT, 2018, 67 : A97 - A97
[37] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
Lim, Jihye
Choi, Won-Mook
Shim, Ju Hyun
Lee, Danbi
Kim, Kang Mo
Lim, Young-Suk
Lee, Han Chu
Choi, Jonggi
LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
[38] Efficacy and Safety of Tenofovir Alafenamide (TAF) at 96 Weeks in Chronic HBV (CHB) Patients with Risk Factors for Use of Tenofovir Disoproxil Fumarate (TDF)
Buti, Maria
Stepanova, Tatjana
Celen, Mustafa K.
Flisiak, Robert
Ryder, Stephen D.
Streinu-Cercel, Adrian
Gurel, Selim
Flaherty, John F.
Gaggar, Anuj
Suri, Vithika
Mo, Shuyuan
Subramanian, Mani
Nurmukhametova, Elena
Zoulim, Fabien
Andreone, Pietro
Marcellin, Patrick
HEPATOLOGY, 2017, 66 : 488A - 488A
[39] 48 WEEKS SAFETY AND EFFICACY OF TENOFOVIR ALAFENAMIDE COMPARED TO TENOFOVIR DISOPROXIL FUMARATE AND ENTERCAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B IN CHINA
Zhang, Yeqiong
Xu, Wenxiong
Wang, Lu
Wu, Lina
Li, Jiangguo
Xie, Chan
Peng, Liang
HEPATOLOGY, 2020, 72 : 474A - 475A
[40] Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study
Janssen, Harry
Heo, Jeong
Fournier, Claire
Ahn, Sang Hoon
Coffin, Carla S.
Hui, Aric Josun
Elkhashab, Magdy
Jafri, Syed-Mohammed
Mo, Shuyuan
Winans, Jake
Flaherty, John
Gaggar, Anuj
Chuang, Wan-Long
Gane, Ed J.
Lim, Young-Suk
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S530 - S530

← 1 2 3 4 5 →